Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 3546 entries
View as:

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT01673490 Org: User:
Start: 06/29/12 End: 03/20/15 Due: 03/20/16

Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug

Phase: N/A Priority: Normal
NCT ID: NCT03235726 Org: User:
Start: 07/13/17 End: 06/19/18 Due: 06/19/19

A Study With Darapladib to Collect Tolerability Information

Phase: N/A Priority: Normal
NCT ID: NCT00704431 Org: User:
Start: 05/31/08 End: 10/31/08 Due: 10/31/09

A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03803202 Org: User:
Start: 01/24/19 End: 09/28/20 Due: 09/28/21

Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women

Phase: N/A Priority: Normal
NCT ID: NCT00334152 Org: User:
Start: 03/31/06 End: 07/31/06 Due: 07/31/07

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00053638 Org: User:
Start: 02/28/03 End: 10/31/04 Due: 10/31/05

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Phase: N/A Priority: Normal
NCT ID: NCT00383227 Org: User:
Start: 12/31/99 End: 11/30/00 Due: 11/30/01

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Phase: N/A Priority: Normal
NCT ID: NCT00861380 Org: User:
Start: 05/04/09 End: 10/05/13 Due: 10/05/14

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT00501462 Org: User:
Start: 07/31/07 End: 03/31/08 Due: 03/31/09

GW406381 In Patients With Peripheral Nerve Injury

Phase: N/A Priority: Normal
NCT ID: NCT00279032 Org: User:
Start: 09/30/03 End: - Due: -

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Phase: N/A Priority: Normal
NCT ID: NCT02849418 Org: User:
Start: 10/11/16 End: 12/20/18 Due: 12/20/19

Study Of Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00358475 Org: User:
Start: 06/21/05 End: 10/12/05 Due: 10/12/06

Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390

Phase: N/A Priority: Normal
NCT ID: NCT00996216 Org: User:
Start: 09/30/09 End: 02/28/13 Due: 02/28/14

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

Phase: N/A Priority: Normal
NCT ID: NCT00609492 Org: User:
Start: 01/03/08 End: 03/30/09 Due: 03/30/10

Post Marketing Surveillance for Contac Bien Z in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02020902 Org: User:
Start: 03/31/13 End: 01/31/16 Due: 01/31/17

A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00475436 Org: User:
Start: 05/14/07 End: 09/18/07 Due: 09/18/08

A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03329547 Org: User:
Start: 01/11/18 End: 02/02/18 Due: 02/02/19

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00394030 Org: User:
Start: 10/16/06 End: 03/20/07 Due: 03/20/08

Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells

Phase: N/A Priority: Normal
NCT ID: NCT00820924 Org: User:
Start: 06/30/08 End: 07/31/11 Due: 07/31/12

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01144663 Org: User:
Start: 07/01/10 End: 09/10/13 Due: 09/10/14

A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679

Phase: N/A Priority: Normal
NCT ID: NCT00511563 Org: User:
Start: 08/31/07 End: - Due: -

Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01782651 Org: User:
Start: 08/31/14 End: 07/31/15 Due: 07/31/16

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01573624 Org: User:
Start: 04/03/12 End: 02/04/13 Due: 02/04/14

Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01159964 Org: User:
Start: 07/20/10 End: 09/10/14 Due: 09/10/15

Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01331694 Org: User:
Start: 07/31/09 End: 05/31/10 Due: 05/31/11